1987
Serum samples from patients with active psoriasis enhance lymphocyte-induced angiogenesis and modulate endothelial cell proliferation
Search citation statements
Paper Sections
Select...
10
0
0
0
Citation Types
0
3
0
2
Year Published
1988
2005
Publication Types
Select...
8
2
Relationship
0
10
Authors
Journals
Cited by 10 publications
(5 citation statements)
References 0 publications
0
3
0
2
“…Previous investigators have observed that peripheral bloodderived mononuclear cells from psoriatic patients, or serum from psoriatic patients, could induce angiogenesis (Majewski et al, 1985(Majewski et al, , 1987; however, the exact cell-type (i.e., T cell subset), or the molecules responsible for this angiogenic response, were not further characterized. More recently, attempts have been made to deĀ®ne the cytokine network in psoriasis, and to identify angiogenic as well as angiostatic cytokines that may contribute to the vascular changes present in psoriatic plaques (Nickoloff, 1991).…”
mentioning
confidence: 99%
“…Previous investigators have observed that peripheral bloodderived mononuclear cells from psoriatic patients, or serum from psoriatic patients, could induce angiogenesis (Majewski et al, 1985(Majewski et al, , 1987; however, the exact cell-type (i.e., T cell subset), or the molecules responsible for this angiogenic response, were not further characterized. More recently, attempts have been made to deĀ®ne the cytokine network in psoriasis, and to identify angiogenic as well as angiostatic cytokines that may contribute to the vascular changes present in psoriatic plaques (Nickoloff, 1991).…”
mentioning
confidence: 99%
“…Functionally, serum factors may modulate chemotaxis of monocytes and neutrophils and may interfere with angioneogenesis and proliferation of fibroblasts [3][4][5][6], Non-cel lular systemic factors which might be involved in the immunopathogenesis of psoriasis are numerous. It has been suggested that IgA and IgA immune complexes are in volved in the pathogenesis of psoriasis [7][8][9].…”
mentioning
confidence: 99%
“…The sera obtained from healthy controls or patients were heat-decomplemented at 56°C for 30 min and tested for their ability to influence NCMC of PBMC from normal healthy donors of blood group 0, according to Majewski et al (1987) with some modifications. Briefly, 2 x lo7 PBMC were incubated in 2 ml of HBSS supplemented with 25% of the tested serum for 3 hr at 37°C.…”
Section: Treatment Of Normal Pbmc With Patients' Seramentioning
confidence: 99%
